Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial Fibrillation
Author(s) -
Denice HodgsonZingman,
Margaret L. Karst,
Leonid V. Zingman,
Denise M. Heublein,
Dawood Darbar,
Kathleen J. Herron,
Jeffrey D. Ballew,
Mariza de Andrade,
John C. Burnett,
Timothy M. Olson
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0706300
Subject(s) - atrial fibrillation , medicine , frameshift mutation , cardiology , atrial natriuretic peptide , cyclic guanosine monophosphate , natriuretic peptide , mutation , endocrinology , gene , heart failure , genetics , biology , nitric oxide
Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom